U.S. FDA expands approval of Roche hemophilia drug

IN -

IN—Roche on Thursday said U.S. regulators approved expanded use of its drug Hemlibra to include almost all patients with hemophilia A, as the Swiss drugmaker increases its focus on diseases beyond cancer to help replace revenue from older products that have lost patent protection.

U.S. FDA expands approval of Roche's bleeding disorder drug. Oct 4 (Reuters) - Roche said on Thursday U.S. regulators approved its hemophilia A drug Hemlibra, expanding its use in nearly all patients, as the Swiss...